
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC285b-3]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
              SUBCHAPTER III--NATIONAL RESEARCH INSTITUTES
 
   Part C--Specific Provisions Respecting National Research Institutes
 
          subpart 2--national heart, lung, and blood institute
 
Sec. 285b-3. National Heart, Blood Vessel, Lung, and Blood 
        Diseases and Blood Resources Program; administrative provisions
        
    (a)(1) The National Heart, Blood Vessel, Lung, and Blood Diseases 
and Blood Resources Program (hereafter in this subpart referred to as 
the ``Program'') may provide for--
        (A) investigation into the epidemiology, etiology, and 
    prevention of all forms and aspects of heart, blood vessel, lung, 
    and blood diseases, including investigations into the social, 
    environmental, behavioral, nutritional, biological, and genetic 
    determinants and influences involved in the epidemiology, etiology, 
    and prevention of such diseases;
        (B) studies and research into the basic biological processes and 
    mechanisms involved in the underlying normal and abnormal heart, 
    blood vessel, lung, and blood phenomena;
        (C) research into the development, trial, and evaluation of 
    techniques, drugs, and devices (including computers) used in, and 
    approaches to, the diagnosis, treatment (including the provision of 
    emergency medical services), and prevention of heart, blood vessel, 
    lung, and blood diseases and the rehabilitation of patients 
    suffering from such diseases;
        (D) establishment of programs that will focus and apply 
    scientific and technological efforts involving the biological, 
    physical, and engineering sciences to all facets of heart, blood 
    vessel, lung, and blood diseases with emphasis on the refinement, 
    development, and evaluation of technological devices that will 
    assist, replace, or monitor vital organs and improve instrumentation 
    for detection, diagnosis, and treatment of and rehabilitation from 
    such diseases;
        (E) establishment of programs for the conduct and direction of 
    field studies, large-scale testing and evaluation, and demonstration 
    of preventive, diagnostic, therapeutic, and rehabilitative 
    approaches to, and emergency medical services for, such diseases;
        (F) studies and research into blood diseases and blood, and into 
    the use of blood for clinical purposes and all aspects of the 
    management of blood resources in the United States, including the 
    collection, preservation, fractionation, and distribution of blood 
    and blood products;
        (G) the education (including continuing education) and training 
    of scientists, clinical investigators, and educators, in fields and 
    specialties (including computer sciences) requisite to the conduct 
    of clinical programs respecting heart, blood vessel, lung, and blood 
    diseases and blood resources;
        (H) public and professional education relating to all aspects of 
    such diseases, including the prevention of such diseases, and the 
    use of blood and blood products and the management of blood 
    resources;
        (I) establishment of programs for study and research into heart, 
    blood vessel, lung, and blood diseases of children (including cystic 
    fibrosis, hyaline membrane, hemolytic diseases such as sickle cell 
    anemia and Cooley's anemia, and hemophilic diseases) and for the 
    development and demonstration of diagnostic, treatment, and 
    preventive approaches to such diseases; and
        (J) establishment of programs for study, research, development, 
    demonstrations and evaluation of emergency medical services for 
    people who become critically ill in connection with heart, blood 
    vessel, lung, or blood diseases.

    (2) The Program shall be coordinated with other national research 
institutes to the extent that they have responsibilities respecting such 
diseases and shall give special emphasis to the continued development in 
the Institute of programs related to the causes of stroke and to 
effective coordination of such programs with related stroke programs in 
the National Institute of Neurological and Communicative Disorders and 
Stroke. The Director of the Institute, with the advice of the advisory 
council for the Institute, shall revise annually the plan for the 
Program and shall carry out the Program in accordance with such plan.
    (b) In carrying out the Program, the Director of the Institute, 
under policies established by the Director of NIH--
        (1) may, after consultation with the advisory council for the 
    Institute, obtain (in accordance with section 3109 of title 5, but 
    without regard to the limitation in such section on the period of 
    such service) the services of not more than one hundred experts or 
    consultants who have scientific or professional qualifications;
        (2)(A) may, in consultation with the advisory council for the 
    Institute, acquire and construct, improve, repair, operate, alter, 
    renovate, and maintain, heart, blood vessel, lung, and blood disease 
    and blood resource laboratories, research, training, and other 
    facilities, equipment, and such other real or personal property as 
    the Director determines necessary;
        (B) may, in consultation with the advisory council for the 
    Institute, make grants for construction or renovation of facilities; 
    and
        (C) may, in consultation with the advisory council for the 
    Institute, acquire, without regard to section 34 of title 40, by 
    lease or otherwise, through the Administrator of General Services, 
    buildings or parts of buildings in the District of Columbia or 
    communities located adjacent to the District of Columbia for the use 
    of the Institute for a period not to exceed ten years;
        (3) subject to section 284(b)(2) of this title and without 
    regard to section 3324 of title 31 and section 5 of title 41, may 
    enter into such contracts, leases, cooperative agreements, or other 
    transactions, as may be necessary in the conduct of the Director's 
    functions, with any public agency, or with any person, firm, 
    association, corporation, or educational institutions;
        (4) may make grants to public and nonprofit private entities to 
    assist in meeting the cost of the care of patients in hospitals, 
    clinics, and related facilities who are participating in research 
    projects; and
        (5) shall, in consultation with the advisory council for the 
    Institute, conduct appropriate intramural training and education 
    programs, including continuing education and laboratory and clinical 
    research training programs.

Except as otherwise provided, experts and consultants whose services are 
obtained under paragraph (1) shall be paid or reimbursed, in accordance 
with title 5, for their travel to and from their place of service and 
for other expenses associated with their assignment. Such expenses shall 
not be allowed in connection with the assignment of an expert or 
consultant whose services are obtained under paragraph (1) unless the 
expert or consultant has agreed in writing to complete the entire period 
of the assignment or one year of the assignment, whichever is shorter, 
unless separated or reassigned for reasons which are beyond the control 
of the expert or consultant and which are acceptable to the Director of 
the Institute. If the expert or consultant violates the agreement, the 
money spent by the United States for such expenses is recoverable from 
the expert or consultant as a debt due the United States. The Secretary 
may waive in whole or in part a right of recovery under the preceding 
sentence.

(July 1, 1944, ch. 373, title IV, Sec. 421, as added Pub. L. 99-158, 
Sec. 2, Nov. 20, 1985, 99 Stat. 837; amended Pub. L. 100-607, title I, 
Sec. 127, Nov. 4, 1988, 102 Stat. 3055; Pub. L. 103-43, title V, 
Sec. 501, title XX, Sec. 2008(b)(3), June 10, 1993, 107 Stat. 158, 211.)

                       References in Text

    The provisions of title 5 relating to reimbursement for travel 
expenses, referred to in subsec. (b), are classified generally to 
section 5701 et seq. of Title 5, Government Organization and Employees.


                               Amendments

    1993--Subsec. (b)(1). Pub. L. 103-43, Sec. 2008(b)(3), inserted 
comma after ``may''.
    Subsec. (b)(5). Pub. L. 103-43, Sec. 501, added par. (5).
    1988--Subsec. (a)(1)(D). Pub. L. 100-607, Sec. 127(1), inserted 
``and rehabilitation from'' after ``and treatment of''.
    Subsec. (b)(1). Pub. L. 100-607, Sec. 127(2), substituted ``after 
consultation with'' for ``, after approval of''.
